MD-Prolintane, also known as methyl-prolintane, is a synthetic stimulant drug belonging to the prolintane class. Structurally similar to other known stimulants such as pyrovalerone, MD-Prolintane acts primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI), which enhances levels of the neurotransmitters norepinephrine and dopamine in the brain. This mechanism of action results in pronounced stimulating and euphoric effects, making it comparable to more well-known substances like methylphenidate or certain amphetamines.
Effects:
The effects of MD-Prolintane can vary significantly depending on dosage, the method of administration, and individual user characteristics. Commonly reported effects include increased alertness, enhanced concentration, elevated mood, and a sense of increased energy. Users may also experience euphoria, especially at higher doses. The onset of effects typically occurs within 20 to 30 minutes when ingested orally, with effects lasting between 4 to 6 hours.
Dosage:
The appropriate dosage of MD-Prolintane can vary based on the user’s experience with stimulants and individual body chemistry. A typical oral dose ranges from 10 to 30 mg. It is strongly recommended that new users begin with the lowest possible dose to assess tolerance. Doses exceeding 30 mg are considered strong and may increase the likelihood of adverse effects.
Side Effects:
As with any stimulant, the use of MD-Prolintane can lead to side effects, particularly at higher doses or with prolonged use. Common side effects include anxiety, restlessness, insomnia, and decreased appetite. Physical side effects may include increased heart rate, elevated blood pressure, and in rare cases, cardiac complications. Users should be cautious of the potential for psychological dependency.
Harm Reduction:
To minimize risks, users should avoid combining MD-Prolintane with other stimulants or depressants, as this can increase strain on the cardiovascular system and potentially lead to adverse reactions. It is also advisable to maintain hydration, take breaks to assess physical and mental state, and ideally, use under supervision or with peers. Regular medical check-ups are recommended to monitor health impacts, especially for those using it on a recurring basis.
Why Buy MD-Prolintane EU from RECHEMCO?
★ We have a long trading history in the market so you benefit from our experience.
★ MD-Prolintane was tested and verified.
★ We accept various payment methods such as Bitcoin, Monero and bank wire.
What you will receive when you buy MD-Prolintane EU from RECHEMCO?
• One sealed aluminum foil bag containing highest grade MD-Prolintane EU
• Crystal
• 98% Purity
asbestos.cloud (verified owner) –
Got it twice from here. Consistency and great quality each time.
Note to fellow researchers: our testing in multiple environments and subjects has shown it to act objectively more like of an odd MD- rather than a typical stimulant, especially at higher doses.
Lab testing results may suggest that the compound can be dosed semi-safely in MDMA-like amounts. Redosing appears to be quite possible in a well-hydrated and thermoregulated environment.
Likely unsafe to mix with SSRIs.
Other findings so far make it appear more like a somewhat sedating (at least physically) MD with a stronger visual aspect, rather than an overwhelmingly energetic one. Think MDA with a touch of K.
Very interesting; hope it gets more attention and some expert reviews.
Rechemco –
Thank you for sharing your experience with MD-Prolitane from asbestos.cloud. It’s interesting to hear that you have found the compound to have effects similar to an odd MD- rather than a typical stimulant, especially at higher doses. Your mention of it being more sedating physically and having a stronger visual aspect is intriguing, as it sets it apart from traditional stimulants.
Your note about the compound possibly being dosed semi-safely in MDMA-like amounts and the importance of hydration and thermoregulation is valuable information for fellow researchers. It’s also helpful to caution against mixing MD-Prolitane with SSRIs, as potential interactions can be risky.
Your findings and observations make MD-Prolitane even more intriguing, and it’s understandable that you hope it garners more attention and expert reviews. Expert opinions and further research can shed more light on its unique effects and potential applications.
Thank you for sharing your insights, and we appreciate your contribution to the conversation about MD-Prolitane.
Calvin Ellis –
Do you ship us
Rechemco –
Thank you for your interest in MD-Prolitane. As stated in the post, all the products from EU Retail can be shipped to EU countries only.
Unfortunately, shipping to the US is not available for any kind of RC and regulated generics.
We apologize for any inconvenience this may cause. If you have any other questions or need further assistance, please let us know.